Since its inception in 2000, Ontario Genomics has supported the commercialization of genomics technologies and products through early-stage funding, co-funding, or creation of these companies:

  • Northern Biologics
  • ProMIS Neurosciences (Amorfix)
  • RNA Diagnostics
  • Savant
  • Tissue Regeneration Therapeutics Inc
  • Vasomune
  • Xagenic Canada Inc.

The following companies were supported by Genome Canada’s Genomics Application Partnership Program (GAPP) in partnership between academic researchers and industry, to promote the application of genomics-derived solutions to address key sector challenges.

  • Xagenic Canada Inc.
  • Vineland Research and Innovation Centre
  • Cooke Aquaculture Inc. and Kelly Cove Salmon Ltd.
  • Assurex Health
  • Vasomune Therapeutics
  • Roche Diagnostics International Ltd.
  • LifeLabs Medical Laboratory Services
  • United Therapeutics (Lung Bioengineering Inc.)